221685-06-9

Upstream product

• 131288-30-7 (2R,4R)-3-Benzyloxycarbonyl-2-phenyl-4-phenylmethyl-5-oxooxazolidine 
• 673-06-3 D-(R)-phenylalanine 
• 221685-05-8 (2R,4S)-4-Benzyl-4-(benzyloxycarbamoyl-methyl)-5-oxo-2-phenyl-oxazolidine-3-carboxylic acid benzyl ester 

Downstream Products

• 221685-07-0 (S)-3-Amino-3-benzyl-1-benzyloxy-pyrrolidine-2,5-dione 
• 221685-09-2 (S)-2-Acetylamino-4-methyl-pentanoic acid ((S)-3-benzyl-1-hydroxy-2,5-dioxo-pyrrolidin-3-yl)-amide 
• 221685-12-7 (R)-2-Acetylamino-4-methyl-pentanoic acid ((S)-3-benzyl-1-hydroxy-2,5-dioxo-pyrrolidin-3-yl)-amide 
• 221685-08-1 (S)-2-Acetylamino-4-methyl-pentanoic acid ((S)-3-benzyl-1-benzyloxy-2,5-dioxo-pyrrolidin-3-yl)-amide 
• 221685-11-6 (R)-2-Acetylamino-4-methyl-pentanoic acid ((S)-3-benzyl-1-benzyloxy-2,5-dioxo-pyrrolidin-3-yl)-amide 

Relevant academic research and scientific papers

Leucine-phenylalanine dipeptide-based N-mesyloxysuccinimides: Synthesis of all four stereoisomers and their assay against serine proteases

The four stereoisomers of 3-(N-acetylleucylamino)-3-benzyl-1- [(methylsulfonyl)oxy]succinimide have been prepared and shown to inhibit α- chymotrypsin and human neutrophil elastase. The structural and stereochemical features that affect the potency and selectivity of inhibition are discussed.